Diabetes Leadership Council Names Congresswoman Diana DeGette, Senator Susan Collins and Senator Jeanne Shaheen as 2022 Diabetes Champions
WASHINGTON, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Diabetes Leadership Council (DLC), a diabetes and health care reform advocacy organization advancing patient-centered policies at the local, state and federal levels, today announced Congresswoman Diana DeGette, Senator Susan Collins and Senator Jeanne Shaheen as its 2022 Diabetes Champions.
“Through their leadership of the Diabetes Caucus and Congressional efforts to reduce insulin costs, Congresswoman DeGette, Senators Collins and Shaheen truly demonstrate a commitment to the 37 million Americans living with diabetes,” said Stewart Perry, Board Chair, Diabetes Leadership Council. “We are proud to recognize them for their dedication and hope their example of ‘Less Talk, More Action’ inspires other members of Congress who pay lip service to our cause but fail to act.”
“As the mother of a daughter with Type-I diabetes, I know firsthand the struggles that millions of Americans face on a daily basis because of this disease,” said DeGette, “and it’s why I remain determined to help find new ways to treat, and eventually cure, this devastating illness. Diseases such as diabetes don’t care if you’re a Democrat or Republican, they affect all of us the same. While we have made significant progress over the years to help the millions of Americans living with diabetes, there’s still a lot more we can do. And I am confident that by working together we can get a lot more done.”
“As the founder and co-chair of the Senate Diabetes Caucus, I have long worked to increase funding for biomedical research, which has produced revolutionary treatment options for those who are affected by this disease. I am also committed to supporting federal policies that will help improve the lives of patients and their families,” said Senator Collins. “The Diabetes Leadership Council is a powerful and effective voice for diabetes patients. I am honored to receive this recognition, and I will continue to build on the progress we have made to better treat, prevent, and ultimately cure diabetes.”
“I’m honored to be named as one of the Diabetes Leadership Council’s 2022 Diabetes Champions. Far too often, Americans living with diabetes are forced to make difficult financial and personal decisions to access insulin and other life-sustaining medications and treatments. That’s unacceptable,” said Shaheen. “In order to ensure affordable access to diabetes care is within reach, it's imperative we continue to fight towards reducing the high cost of insulin and extending patient protections. Through my work as co-chair of the Senate Diabetes Caucus, I’ll keep advocating for federal action to address this issue and bring about much-needed relief for the millions of Americans and their families impacted by this chronic condition.”
About the Diabetes Leadership Council Champion Award:
The Diabetes Leadership Council presents the award to the most effective lawmakers based on their public commitment and legislative actions to increase health care access and affordability for Americans with chronic health conditions, particularly the 37 million individuals living with diabetes and 90 million who have pre-diabetes.
About Congresswoman DeGette:
Congresswoman DeGette represents Colorado’s first district and is the Democratic co-chair of the Congressional Diabetes Caucus. She is also the chair of the Energy and Commerce Oversight and Investigations Subcommittee, which directly oversees the nation’s health industry. In the 117th Congress, Congresswoman DeGette also leads efforts on Cures 2.0 and the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the delivery of groundbreaking and lifesaving cures, treatments and innovations aimed at ending some of the world’s most difficult diseases. Along with fellow award winners, Congresswoman DeGette continues to support health care affordability beyond insulin by supporting Medicare coverage of continuous glucose monitoring (CGM) and other medical devices crucial to the management of diabetes.
About Senator Collins:
Senator Collins represents the state of Maine. She sits on the Senate Committees on Appropriations and Health, Education, Labor and Pensions. In the 117th Congress, Senator Collins along with Senator Jeanne Shaheen has spearheaded the INSULIN Act, which seeks to reduce list prices of insulin while extending patient protections that will foster competition and broader access to insulin products. In addition to her efforts to support insulin affordability, Senator Collins continues to support improved Medicare coverage of Continuous Glucose Monitoring (CGM) and other devices that play a crucial role in diabetes care.
About Senator Shaheen:
Senator Shaheen represents the state of New Hampshire. She sits on the Senate Appropriations Committee. In the 117th Congress, Senator Shaheen along with Senator Susan Collins has spearheaded the INSULIN Act, which seeks to increase measures to reduce list prices of insulin while extending patient protections that will foster competition and broader access to desperately needed insulin products. In addition to her efforts to support insulin affordability, Senator Shaheen continues to support improved Medicare coverage of Continuous Glucose Monitoring (CGM) and other devices that play a crucial role in diabetes care.
DLC is a 501(c)(3) patient advocacy organization comprised of individuals who combine their passion for advocacy with decades of diabetes experience and leadership to advance patients-first policies at the local, state and national levels. Our members – all former leaders of national diabetes organizations – engage policymakers, and public and private sector influencers to call attention to the diabetes epidemic and provide a voice for 37 million Americans living with the disease
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
FootballCoin Announces World Cup-Inspired Fantasy Football Contests3.12.2022 20:31:15 CET | Press release
The Fantasy Football World Cup 2022 is finally here. LONDON, Dec. 03, 2022 (GLOBE NEWSWIRE) -- FootballCoin, a blockchain-powered fantasy football game, has announced the launch of the Fantasy Football World Cup 2022. The World Cup-inspired contests provide players with the opportunity to collect all of the player NFTs available in-game, as well as earn crypto prizes. Established in 2017, FootballCoin was built using blockchain technology. Today, it has blossomed to become one of the oldest play-to-earn games in the crypto space. An entirely free-to-play game, FootballCoin features cryptocurrency prizes that can be won and converted into real money. However, this game does not involve gambling of any kind. Instead, players are challenged to leverage their football knowledge in order to win prizes such as collectible player cards that live on the blockchain, unique NFTs that can be used to enhance a user's fantasy football squad, and other daily prizes. FootballCoin will host World Cup
Major shareholder notification – Norges Bank3.12.2022 14:45:28 CET | Press release
GN Store Nord A/S hereby announces that on December 2, 2022, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from Norges Bank stating that on December 1, 2022 Norges Bank decreased its aggregate holding of shares and financial instruments, cf. Section 38(1) and Section 39(2)(1) of the Danish Capital Markets Act, to under 5% of the share capital and voting rights in GN Store Nord A/S. For further information, please contact: Investors and analysts Anne Sofie Staunsbæk Veyhe Vice President – Investor Relations, Treasury & M&A Tel: +45 45 75 85 06 or Rune Sandager Senior Director – Investor Relations Tel: +45 45 75 92 57 Press and the media Steen Frentz Laursen Vice President, Corporate Communications Tel: +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliv
Brookfield Announces Reset Dividend Rate on Its Series 30 and Series 48 Preference Shares3.12.2022 03:45:00 CET | Press release
All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Brookfield (NYSE: BAM, TSX: BAM.A) today announced that it has determined the fixed dividend rate on its Cumulative Class A Preference Shares, Series 30 (“Series 30 Shares”) (TSX: BAM.PR.Z) for the five years commencing January 1, 2023 and ending December 31, 2027, and also determined the fixed dividend on its Cumulative Class A Preference Shares, Series 48 (“Series 48 Shares”) (TSX: BAM.PF.J) for the five years commencing January 1, 2023 and ending December 31, 2027. As previously disclosed, the Series 30 Shares and Series 48 Shares are expected to commence trading on the TSX under the updated symbols “BN.PR.Z” and “BN.PF.J”, respectively, on December 12, 2022. Series 30 Shares and Series 31 Shares If declared, the fixed quarterly dividends on the Series 30 Shares during the five years commencing January 1, 2023 will be paid at an annual rate of 6.089% ($0.3805625 per share per
EverWind selects Black & Veatch for Front-end Engineering Design of First Green Hydrogen Hub in Nova Scotia2.12.2022 20:23:30 CET | Press release
HALIFAX, Nova Scotia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- EverWind Fuels Company ("EverWind") today announces it has selected Black & Veatch to provide front-end engineering design (FEED) services for its green hydrogen and ammonia production and storage facility in Point Tupper, Nova Scotia, with initial commercial operations planned for 2025. EverWind is a private developer of green hydrogen and ammonia production and storage sites, and global engineering and construction company Black & Veatch is a green energy solutions leader. In its first phase, the facility will produce green hydrogen and green ammonia through electrolysis using certified green power from the Nova Scotia Power transmission system; onshore wind generation will power production in a second phase. In future phases, EverWind will use offshore wind power to produce hydrogen through electrolysis, unlocking Nova Scotia’s offshore wind capabilities. The first two phases will produce a combined 1 million tonnes per annum o
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA2.12.2022 19:00:00 CET | Press release
Negma Group has converted 322convertible bonds in Oxurion resulting in a EUR 805,000capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion. Leuven, BELGIUM,Boston, MA, US–December2, 2022– 07.00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), announces the below information, following (i) the issuance of 63,550,419 new ordinary shares on November 28, 2022, for a total amount of EUR 605,000, as the result of the conversion of 242 class B convertible bonds, and (ii) the issuance of 21,008,403 new ordinary shares on November 30, 2022, for a total amount